AGIO Stock Analysis: Buy, Sell, or Hold?
AGIO - Agios Pharmaceuticals, Inc.
$35.54
0.44 (1.25%)
▲
5d:
+11.69%
30d:
+23.45%
90d:
+26.43%
WAIT
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Get Alerted When AGIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AGIO is 15.7% above its trading range ($30.73). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AGIO is 15.7% above its trading range ($30.73). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AGIO is currently trading at $35.54, which is considered extended relative to its 30-day fair value range of $27.34 to $30.73.
Technical Outlook: Technically, AGIO is showing sideways momentum. The price is approaching resistance at $35.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AGIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.75 (+16.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AGIO is showing sideways momentum. The price is approaching resistance at $35.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AGIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.75 (+16.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$27.34 -
$30.73
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- BEARISH: Price significantly overextended (+15.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($40.75)
- WARNING: Recommendation downgraded due to 15.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$27.34 -
$30.73
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$26.89
Resistance Level
$35.53
Current Trend
Sideways
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.36
Wall Street Target
$40.75
(+16.1%)
Revenue Growth (YoY)
137.7%
Share & Embed Analysis
Last updated: June 23, 2026 10:04 AM ET
Data refreshes hourly during market hours. Next update: 11:04 AM
Data refreshes hourly during market hours. Next update: 11:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGIO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
James William Burns
SELL
3280 shares
2026-04-02
Sarah Gheuens
SELL
2940 shares
2026-04-02
Tsveta Milanova
SELL
3262 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 56 HOLD |
